{"id":3756,"date":"2009-11-02T00:00:00","date_gmt":"2009-11-02T00:00:00","guid":{"rendered":"https:\/\/psi2030.wpengine.com\/thousands-lack-access-to-effective-anti-malarial-treatment\/"},"modified":"2018-05-22T22:26:56","modified_gmt":"2018-05-22T22:26:56","slug":"thousands-lack-access-to-effective-anti-malarial-treatment","status":"publish","type":"news","link":"https:\/\/www.psi.org\/fr\/news\/thousands-lack-access-to-effective-anti-malarial-treatment\/","title":{"rendered":"Thousands lack access to effective anti-malarial treatment"},"content":{"rendered":"<p><strong>New malaria research unveiled today in Kenya finds that thousands of people die each year because they can&#8217;t afford &#8211; or don&#8217;t have access to &#8211; the most effective form of treatment, called artemisinin-based combination therapies or ACTs.<\/strong> <\/p>\n<p>The ACTwatch research project, funded by the Bill and Melinda Gates Foundation, focuses on the availability, price and use of the drugs in seven African countries and Cambodia.<\/p>\n<p>Desmond Chavasse is Vice President for Malaria Control and Child Survival at Population Services International (PSI), and project director of ACTwatch. <\/p>\n<p>He told RFI that ACTwatch&#8217;s researchers had asked parents where they would seek treatment for children with symptoms of malaria. In most cases, the first port of call would be a private pharmacy rather than a government health facility.<\/p>\n<p>&#8220;When they get there, they generally will not find ACTs there \u2013 and if they do, they\u2019ll find that they are so expensive that they can\u2019t afford them.&#8221;<\/p>\n<p>ACTwatch found that ACTs are 10 to 20 per cent more expensive in the private sector than the most commonly available anti-malarials.<\/p>\n<p>Dr Chevasse says that &#8220;this is ultimately what\u2019s leading to the fact that most children in Africa are either not being treated at all for malaria &#8211; or they\u2019re being treated with ineffective drugs.&#8221;<\/p>","protected":false},"template":"","related_countries":[],"related_projects":[],"news_category":[],"health-area":[],"capabilities-and-cross-cutting":[],"class_list":["post-3756","news","type-news","status-publish","hentry"],"aioseo_notices":[],"_links":{"self":[{"href":"https:\/\/www.psi.org\/fr\/wp-json\/wp\/v2\/news\/3756","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.psi.org\/fr\/wp-json\/wp\/v2\/news"}],"about":[{"href":"https:\/\/www.psi.org\/fr\/wp-json\/wp\/v2\/types\/news"}],"wp:attachment":[{"href":"https:\/\/www.psi.org\/fr\/wp-json\/wp\/v2\/media?parent=3756"}],"wp:term":[{"taxonomy":"related_countries","embeddable":true,"href":"https:\/\/www.psi.org\/fr\/wp-json\/wp\/v2\/related_countries?post=3756"},{"taxonomy":"related_projects","embeddable":true,"href":"https:\/\/www.psi.org\/fr\/wp-json\/wp\/v2\/related_projects?post=3756"},{"taxonomy":"news_category","embeddable":true,"href":"https:\/\/www.psi.org\/fr\/wp-json\/wp\/v2\/news_category?post=3756"},{"taxonomy":"health-area","embeddable":true,"href":"https:\/\/www.psi.org\/fr\/wp-json\/wp\/v2\/health-area?post=3756"},{"taxonomy":"capabilities-and-cross-cutting","embeddable":true,"href":"https:\/\/www.psi.org\/fr\/wp-json\/wp\/v2\/capabilities-and-cross-cutting?post=3756"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}